SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

CORONA Remedies - Quaterly Results

12 May 2026 Evaluate
The company witnessed a 20.23% growth in the revenue at Rs. 3530.90 millions for the quarter ended March 2026 as compared to Rs. 2936.90 millions during the year-ago period.A good growth in profit of 43.75% reported to Rs. 450.50  millions over Rs. 313.40 millions of corresponding previous quarter.Operating profit surged to 661.30 millions from the corresponding previous quarter of 556.40 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 3530.90 2936.90 20.23 14031.80 11964.20 17.28 14031.80 11964.20 17.28
Other Income 41.10 14.20 189.44 106.50 59.30 79.60 106.50 59.30 79.60
PBIDT 661.30 556.40 18.85 3040.90 2459.10 23.66 3040.90 2459.10 23.66
Interest 13.80 22.00 -37.27 69.70 106.00 -34.25 69.70 106.00 -34.25
PBDT 647.50 534.40 21.16 2780.20 2353.10 18.15 2780.20 2353.10 18.15
Depreciation 102.90 100.40 2.49 378.70 371.60 1.91 378.70 371.60 1.91
PBT 544.60 434.00 25.48 2401.50 1981.50 21.20 2401.50 1981.50 21.20
TAX 94.10 120.60 -21.97 553.00 491.00 12.63 553.00 491.00 12.63
Deferred Tax 51.80 28.20 83.69 38.20 43.00 -11.16 38.20 43.00 -11.16
PAT 450.50 313.40 43.75 1848.50 1490.50 24.02 1848.50 1490.50 24.02
Equity 611.60 611.60 0.00 611.60 611.60 0.00 611.60 611.60 0.00
PBIDTM(%) 18.73 18.95 -1.14 21.67 20.55 5.44 21.67 20.55 5.44

CORONA Remedies Share Price

1833.30 0.65 (0.04%)
19-Jun-2026 09:09 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1825.40
Dr. Reddys Lab 1263.40
Cipla 1355.75
Zydus Lifesciences 1079.20
Lupin 2293.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: